Newsroom

Sorted by: Latest

-

Kenvue Declares Quarterly Cash Dividend

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as of the close of business on May 13, 2026. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Li...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 28.04.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,066,962.67 63.436  ...
-

Evercore Reports Record First Quarter 2026 Revenues; Increases Quarterly Dividend to $0.89 Per Share

NEW YORK--(BUSINESS WIRE)--Evercore Inc. (NYSE: EVR):   First Quarter Results   U.S. GAAP   Adjusted   Q1 2026 Q1 2025   Q1 2026 Q1 2025 Net Revenues ($ mm) $ 1,391.6   $ 694.8     $ 1,401.5   $ 699.9   Operating Income ($ mm) $ 330.7   $ 111.2     $ 354.5   $ 116.3   Net Income Attributable to Evercore Inc. ($ mm) $ 301.2   $ 146.2     $ 334.7   $ 154.8   Diluted Earnings Per Share $ 7.20   $ 3.48     $ 7.53   $ 3.49   Compensation Ratio   65.0 %   66.2 %     64.0 %   65.7 % Operating Margin  ...
-

Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who received at least one prior line of treatment. The study demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of progression‑free survival (PFS), as assessed by blinded independent central review (BICR), v...
-

OneSpaWorld Reports Record First Quarter Fiscal 2026 Results

NASSAU, Bahamas--(BUSINESS WIRE)--OneSpaWorld Holdings Limited (NASDAQ: OSW) (“OneSpaWorld,” or the “Company”), the pre-eminent global provider of health and wellness services and products onboard cruise ships and in destination resorts around the world, today announced financial results for the first quarter ended March 31, 2026. Leonard Fluxman, Executive Chairman and Chief Executive Officer, commented: “We began the year with continuing strong momentum through the first quarter, reporting be...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 28.04.2026 FGBL.LN IE00BYTH6121 1,020,847.00 USD 97,269,558.71 95.283  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 28.04.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,419,979.80 28.975  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 28.04.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,664,672.27 41.438  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 28.04.2026 EDVY.LN IE000CPG9HG3   50,002.00 EUR   1,038,524.37   20.770  ...
-

Freed Launches Coding Assistant for Independent Practices

SAN FRANCISCO--(BUSINESS WIRE)--Freed, the AI clinical documentation platform serving 26,000+ clinicians, today announced Coding Assistant, an AI tool that helps independent practices capture accurate reimbursement from every patient encounter. The feature generates ICD-10 and CPT codes at the appropriately justified E/M level while automatically strengthening documentation to reduce denial risk. The coding crisis crushing small practices Most physicians get zero coding education in medical sch...